ChEM-H Institute Scholars are hired by the institute through broad area searches in conjunction with Stanford schools and departments. Our Institute Scholars have been appointed into the schools of Engineering, Humanities & Sciences and Medicine and will have their primary research labs in the new Stanford Neurosciences-ChEM-H Research Complex.
Carolyn Bertozzi
Anne T. and Robert M. Bass Professor of Chemistry, Chemical & Systems Biology, and Radiology (by courtesy) and Howard Hughes Medical Institute Investigator
“I see the opportunity to create a new kind of training program that positions our students to make giant leaps in therapeutic science. We’re going to create a new model for training chemists, engineers and physician-scientists who, themselves, will be primed to revolutionize the way medicines are conceived, created and implemented.” ~Carolyn Bertozzi
Laura Dassama
Assistant Professor of Chemistry
“I was always doing more biological work in a chemistry department, or the chemist in a more biological department. ChEM-H will feel like home, as no one here is a traditional chemist, biologist, or engineer.” ~Laura Dassama
Michael Fischbach
Associate Professor of Bioengineering
“In academia and industry, breakthroughs that change the landscape tend to happen when a fantastic group of people are co-located and given a charge to change the way science is done. Those ingredients are what make me excited about ChEM-H.” ~Michael Fischbach
Polly Fordyce
Assistant Professor of Genetics and Bioengineering
“Being part of ChEM-H will help me push my work toward a focus on disease. I like the idea of trying to bring people from chemistry, engineering and medicine together with the broad goal of improving human health. Everyone talks about blurring departmental boundaries but an institute like this really allows it to happen.” ~Polly Fordyce
Peter Kim
Virginia and D.K. Ludwig Professor of Biochemistry
“What I can bring to the table is an additional perspective that encompasses the pharmaceutical side of this equation. It's important that academic work that can be translated does get translated. I'll certainly be looking, at the institutional level, for ways to make it easier for individuals to navigate the translational pathway.” ~Peter Kim
Lingyin Li
Assistant Professor of Biochemistry
“I am a chemist by training but a biologist at heart .” ~Lingyin Li
Jonathan Long
Assistant Professor of Pathology
“ChEM-H is a truly unique opportunity to build bridges between the chemical sciences and clinical medicine at a level that I have never seen before. It’s exciting to be part of this growing Institute at the interface of disease mechanisms, molecules, new technologies, and clinical practice. I hope that these kinds of multidisciplinary interactions will help to expand my own research program in creative and unconventional ways.” ~Jonathan Long
Stanley Qi
Assistant Professor of Bioengineering and Chemical and Systems Biology
“The ability to work closely with other ChEM-H faculty is very attractive. To be able to learn from them will dramatically help my future research.” ~Stanley Qi
ChEM-H Faculty Hires in the News
Researchers modify CRISPR to reorganize genome
Using a new variation of gene-editing technology CRISPR, Stanford ChEM-H Institute Scholar Stanley Qi and colleagues were able to change the spatial organization of DNA in cell nuclei and show how physical relocation altered cell function.
Moving DNA to a different part of the nucleus can change how it works
ChEM-H Institute Scholar Stanley Qi is using a new CRISPR approach called CRISPR-GO to rearrange DNA in the nucleus.
An interdisciplinary future for ChEM-H: Catching up with Carolyn Bertozzi
Learn more about all that Stanford ChEM-H and Baker Family Co-Director Carolyn Bertozzi are doing to connect basic scientists, engineers, and clinicians to advance human health.
Chemist Carolyn Bertozzi on bridging chemistry and medicine
As chemist Carolyn Bertozzi takes on a new role as Baker Family Co-Director, Stanford ChEM-H, she talks about bridging gaps between chemistry research and medical practice and preparing graduate students for the future.
The doctor is in...your gut
Stanford ChEM-H institute scholar Michael Fischbach is exploring the molecules our gut bacteria produce to better understand how they affect our health.
Digging into the genetic recipe book
Stanford ChEM-H faculty fellow Polly Fordyce discusses her recent paper published in PNAS. Co-authors include ChEM-H postdoc mentor and undergraduate scholar pair, Daniel Le and Allison Keys, and CBI graduate student, Arjun Aditham.
Carolyn Bertozzi elected to Royal Society
Stanford ChEM-H faculty fellow Carolyn Bertozzi has been elected as one of this year’s ten new Foreign Members to the Royal Society for her pioneering work in the field of bioorthogonal chemistry.
New test by Stanford researchers brings faster, cheaper and more reliable tuberculosis diagnosis to rural South Africa
Stanford ChEM-H faculty fellow Carolyn Bertozzi and graduate students in her lab have developed a new tuberculosis test designed to work in low-resource settings.
A new kind of homing beacon targets cancerous cells and other diseases
Stanford ChEM-H faculty fellow Stanley Qi and his team used gene-editing techniques to create human immune cells that target and kill cancerous cells, such as leukemia. The approach could be adapted to an array of diseases ranging from solid tumors to neurological and autoimmune disorders.
Stanford researchers develop a hassle-free HIV test that works better, sooner
Stanford ChEM-H faculty fellow Carolyn Bertozzi and her research group have developed a new needle-free HIV test.
Druglike molecules produced by gut bacteria can affect gut, immune health
Stanford ChEM-H faculty fellows Michael Fischbach and Justin Sonnenberg found that manipulating the gut microbe Clostridium sporogenes changed levels of molecules in the bloodstreams of mice and, in turn, affected their health.
A rare disease inspires Stanford researchers to find a new way to attack cancer
Stanford ChEM-H faculty fellow Carolyn Bertozzi's investigations into a rare disease called NGLY1 deficiency may lead to a new way to treat multiple myeloma and other cancers.
Five researchers receive NIH funding for innovative projects
Stanford ChEM-H faculty fellow Lingyin Li is one of five scientists at Stanford and 86 scientists nationwide to receive an award from the National Institutes of Health High-Risk, High-Reward program. Li received an NIH New Innovator Award which provides up to $1.5 million over five years to fund innovative research by investigators who are within 10 years of their final degree or clinical residency and who have not yet received a research project grant or the equivalent from the NIH.
A bioengineering class helped Stanford researchers understand coral bleaching and more
Stanford ChEM-H faculty fellow Polly Fordyce launches a new course aimed at pairing students interested in building tiny devices with scientists studying coral bleaching, parasites, molecular biology and more.
For Bay Area family affected by rare disease, renewed hope
Stanford ChEM-H Faculty Fellow Carolyn Bertozzi is part of a diverse team of researchers and clinicians tackling the rare genetic disorder NGLY1 Deficiency.
Peter Kim: Sizing Up Structures and Subverting Disease
Stanford ChEM-H Faculty Fellow Peter Kim discusses his career path and research interests as a Rita Allen Foundation Scholar.
Stanford ChEM-H Faculty Fellow Named 2017 Avant-Garde Award Recipient
Stanford ChEM-H faculty fellow Peter Kim was one of three investigators selected to receive the 2017 Avant-Garde Award for HIV/AIDS Research from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH).
The beadnik: Polly Fordyce uses something tiny to do something big
Stanford ChEM-H faculty fellow Polly Fordyce and her team use microfluidic tools to understand protein interactions in the body — knowledge that could help researchers develop therapeutics for a variety of diseases.
Two ChEM-H Faculty Fellows Named 2017 Sloan Research Fellows
Stanford ChEM-H faculty fellows Polly Fordyce and Stanley Lei Qi were among 126 early-career scholars selected as 2017 Sloan Research Fellows. The Alfred P. Sloan Foundation selected fellows who represent the most promising scientific researchers working today. Their achievements and potential place them among the next generation of scientific leaders in the U.S. and Canada.
Polly Fordyce Among 19 Stanford Faculty Selected in First Cohort of Chan Zuckerberg Biohub Investigators
Stanford ChEM-H faculty fellow Polly Fordyce was among 19 Stanford faculty and 10 total ChEM-H faculty fellows selected in the first cohort of investigators for the Chan Zuckerberg Biohub.
Graduate Student's Journey from Africa to the Bertozzi Lab at Stanford Profiled on NPR
NPR interviewed Mireille Kamariza, a graduate student in ChEM-H Faculty Fellow Carolyn Bertozzi's research group, about her journey from Burundi to graduate student at Stanford working on a promising new test to detect tuberculosis.
Stanford ChEM-H Faculty Fellow Awarded NIH New Innovator Award
Polly Fordyce, Stanford ChEM-H Faculty Fellow, is one of of six exceptional early career scientists at Stanford to be awarded the 2016 NIH New Innovator Award. The New Innovator Award provides up to $1.5 million over five years to fund innovative research by an investigator who has not yet received a research project grant or the equivalent from the NIH.
Stanford ChEM-H Faculty Fellow Selected to Lead Chan Zuckerberg Biohub Infectious Diseases Initiative
The Chan Zuckerberg Biohub will include two major research projects intended to help cure and prevent disease. One, focusing on infectious disease, will be led by biochemist and ChEM-H faculty recruit Peter S. Kim.
Stanford chemists develop a new method of cancer immunotherapy
A team of Stanford ChEM-H scientists led by Carolyn Bertozzi has discovered a novel form of cancer immunotherapy, which works by removing certain sugars from the surface of cancer cells and making those cells visible to the immune system.
Simple test could quickly detect tuberculosis in developing countries
Carolyn Bertozzi, Stanford ChEM-H Faculty Fellow, was interviewed by Science Magazine on work she presented at the American Chemical Society (ACS) meeting in Philadelphia, PA, on the development of a simple test to detect tuberculosis.
Stanford ChEM-H Faculty Fellow Named Pew Scholar in the Biomedical Sciences
Stanley Qi, Stanford ChEM-H Faculty Fellow, is one of 22 exceptional early-career scientists named as a Pew scholars in the biomedical sciences by the Pew Charitable Trust this year. The 2016 class of Pew biomedical scholars is drawn from prestigious institutions across the country, with each scholar receiving four years of flexible funding to pursue foundational, innovative research.
Don’t despair in the face of failure, biochemist tells grads
ChEM-H Faculty Fellow Peter Kim addressed the graduates at the 2016 Stanford School of Medicine commencement ceremony.
Stanford chemists develop an ultra-sensitive test for cancers and HIV
ChEM-H Faculty Fellow Carolyn Bertozzi has developed a new diagnostics tool with broad applicability.
“Unprecendented” approach for attempting to create an HIV vaccine
Peter Kim discusses why he thinks he’ll succeed where so many have failed in their efforts to develop an HIV vaccine, and the importance of working across disciplines.
National Academy of Engineering Elects 80 Members and 22 Foreign Members
The National Academy of Engineering announced ChEM-H faculty fellow Peter Kim as a newly elected member.
Work of ChEM-H Faculty Fellow Stanley Qi Profiled in "The Atlantic"
Stanley Qi is gaining attention for his work to modify the popular gene-editing enzyme CRISPR. The modified enzyme is a powerful tool to study and modulate gene function with novel therapeutic potential.
